BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 11:47:00 AM | Browse: 1465 | Download: 1989
 |
Received |
|
2013-07-23 09:37 |
|
Peer-Review Started |
|
2013-07-24 13:48 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-09-03 21:35 |
|
Revised |
|
2013-10-06 21:47 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-10-21 17:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-10-22 07:43 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-01-10 14:57 |
|
Publish the Manuscript Online |
|
2014-02-19 16:57 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Heung Cheol Kim, Ki Tae Suk, Dong Joon Kim, Jai Hoon Yoon, Yeon Soo Kim, Gwang Ho Baik, Jin Bong Kim, Chang Hoon Kim, Hotaik Sung, Jong Young Choi, Kwang Hyub Han and Seung Ha Park |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Korea Healthcare Technology R and D Project, Ministry of Health and Welfare, Republic of Korea |
HI10C2020 |
| Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology |
NRF-2010-0021482 |
|
| Corresponding Author |
Dong Joon Kim, MD, PhD, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon 200-704, South Korea. djkim@hallym.ac.kr |
| Key Words |
Carcinoma; Hepatocellular; Chemoembolization; Therapeutic; Survival; Stage; Efficacy |
| Core Tip |
In this study, transarterial chemoembolization (TACE) was associated with a relatively good survival rate in patients with stage 0 and stage A Barcelona Clinic Liver Cancer (BCLC). The Child-Pugh score, presence of arterio-venous shunt, amount of lipiodol used during TACE, and female gender were correlated with mortality in patients with BCLC stage 0 and stage A hepatocellular carcinoma who underwent TACE. Patients with more than 2 risk factors should be treated by other curative-intent treatments after the first TACE. |
| Publish Date |
2014-02-19 16:57 |
| Citation |
Kim HC, Suk KT, Kim DJ, Yoon JH, Kim YS, Baik GH, Kim JB, Kim CH, Sung H, Choi JY, Han KH, Park SH. Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma. World J Gastroenterol 2014; 20(3): 745-754
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i3/745.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i3.745 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
